Refractec’s ViewPoint Gains FDA Approval For Limited Diopter Range
This article was originally published in The Gray Sheet
Executive Summary
Refractec's eight direct sales reps immediately will begin marketing the ViewPoint CK system, which allows +1.0 to +2.25 diopters of presbyopia correction, as recommended by FDA's Ophthalmic Devices Panel